Our mission is to deliver breakthrough innovations that extend and improve the lives of people with cancer. We are working to prevent cancer where we can and give patients more ways to treat their cancer, more quality in their lives and more time. Everyone knows someone who has been touched by cancer. When that diagnosis happens, what matters most isn't what the next breakthrough is - but when it will get here.

At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie's oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types.

We Believe The Greatest Impact Starts With The Boldest Questions. With Advances In Data And Technology, Genentech Is Changing Healthcare As We Know It. The Resilience Effect. Inclusive Research. Health Equity. Types: Patient Vision Care, Inclusive Care.